Remodeling of Cardiac Gap Junctional Cell-Cell Coupling

Area of Science:

• Cardiovascular physiology
• Molecular cardiology
• Cardiac electrophysiology

Background:

• The heart functions as a syncytium through cell-cell coupling via gap junction channels, essential for action potential propagation.
• Gap junctions are formed by connexons (hemichannels) composed of connexin proteins, with Cx43, Cx40, and Cx45 being key isoforms in the heart.
• These channels are crucial for cardiac electrical conductivity and anisotropy, primarily located at cardiomyocyte poles.

Purpose of the Study:

• To review the role of gap junctions and connexins in cardiac electrical activity.
• To explore how cardiac remodeling processes in diseases like atrial fibrillation and myocardial infarction affect gap junction function.
• To highlight the potential for pharmacological interventions targeting gap junction remodeling.

Main Methods:

• Review of existing literature on cardiac gap junctions, connexins, and cardiac remodeling.
• Analysis of the molecular mechanisms underlying connexin expression modulation.
• Examination of the impact of altered gap junction localization on cardiac conduction and anisotropy.

Main Results:

• Gap junction channels, formed by connexins, facilitate low-resistance electrical coupling and small molecule passage.
• Cardiac remodeling involves changes in connexin expression and gap junction localization, influenced by factors like angiotensin and mechanical forces.
• Reduced connexin expression or altered gap junction localization can decrease conduction velocity, alter conduction pathways, and create an arrhythmogenic substrate.

Conclusions:

• Gap junctions are dynamic structures susceptible to remodeling in cardiac disease, impacting electrical propagation.
• Connexin expression and gap junction localization are key determinants of cardiac electrical anisotropy and arrhythmogenesis.
• Pharmacological strategies targeting these remodeling processes hold promise for treating cardiac arrhythmias.